PepGen Inc. Company Profile
NASDAQ: PEPGHealthcareBiotechnologyUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 2.39 -0.42%
PepGen at a glance
PepGen Inc. (NASDAQ: PEPG) is a Biotechnology company in the Healthcare sector headquartered in Boston, MA. PepGen is led by Dr. James G. McArthur Ph.D. and employs about 57 people. The company's shares have traded publicly since 2022.
At a market capitalization of $166.0 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001835597, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does PepGen do?
PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.
Business description based on the company's public filings.
Company information
- Legal name
- PepGen Inc.
- Ticker
- NASDAQ: PEPG
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. James G. McArthur Ph.D.
- Employees
- 57
- Headquarters
- 321 Harrison Avenue, Boston, MA, United States
- Phone
- 781 797 0979
- Website
- pepgen.com
- IPO year
- 2022
- Market cap
- $166.01M
- SEC CIK
- 0001835597
- Latest annual report
- 10-K · Mar 4, 2026
Companies similar to PepGen
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MDWDMediWound Ltd. | 12.85 | -2.28% | $165.90M | vs PEPG |
| CUECue Biopharma Inc. | 22.51 | -2.72% | $163.52M | vs PEPG |
| NKTXNkarta Inc. | 2.27 | -1.73% | $162.59M | vs PEPG |
| VRXAVeraxa Biotech AG | 1.20 | +11.11% | $169.69M | vs PEPG |
| IPHAInnate Pharma S.A. ADS | 1.52 | -4.40% | $169.78M | vs PEPG |
| MSLESatellos Bioscience Inc. | 7.63 | +1.19% | $161.88M | vs PEPG |
| DTILPrecision BioSciences Inc. | 6.25 | +0.81% | $172.51M | vs PEPG |
| NBPNovaBridge Biosciences ADR | 1.37 | -2.14% | $158.92M | vs PEPG |